Adagene (ADAG) Earnings Date & Reports

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ADAG is expected to report earnings to rise 53.30% to -15 cents per share on September 02

Q2'26

Est.

$-0.15

Q1'26

Beat

by $0.15

Q4'25

Beat

by $0.15

Q2'25

Beat

by $0.10

Q4'24

Beat

by $0.18

The last earnings report on June 03 showed earnings per share of -10 cents, beating the estimate of -25 cents. With 250.19K shares outstanding, the current market capitalization sits at 235.88M.

View a ticker or compare two or three

Compare

ADAG

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ADAG